Related Experiment Video

Updated: Jul 7, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development

Wendy van Veelen1, Carola J R van Gasteren, Dennis S Acton

  • 1Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, the Netherlands.

Cancer Research
|March 5, 2008
PubMed

Insights

Activating RET mutations and loss of the P18 cell cycle inhibitor cooperate to drive medullary thyroid carcinoma (MTC) development and progression. This study reveals a critical genetic interaction in MTC tumorigenesis.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Activating RET proto-oncogene mutations are linked to medullary thyroid carcinoma (MTC).
  • Genetic mechanisms of MTC tumorigenesis are not fully understood.
  • Somatic inactivating mutations in the P18 cell cycle inhibitor gene were found in human MTC.

Purpose of the Study:

  • To investigate the combined role of oncogenic RET and P18 loss in MTC development.
  • To explore the impact of P18 deficiency on MTC progression in the context of RET activation.

Main Methods:

  • Crossed transgenic mice expressing oncogenic RET (RET2B) with mice lacking p18.
  • Monitored MTC development, incidence, age of onset, and tumor size in genetically modified mice.
  • Assessed P18(Ink4c) expression, proliferation rates, and MTC progression in tumor samples.

Main Results:

  • Mice with both oncogenic RET and P18 deficiency (RET2B;p18(-/-)) showed a significantly increased incidence of MTC.
  • Oncogenic RET accelerated MTC onset and increased tumor size in p18-deficient mice.
  • Loss of P18 expression in MTCs correlated with higher proliferation and larger tumors, indicating enhanced progression.

Conclusions:

  • Oncogenic RET and loss of P18 cooperate in the multistep tumorigenesis of medullary thyroid carcinoma.
  • The combined genetic alterations significantly increase MTC risk and promote tumor progression.
  • These findings highlight a critical interplay between cell cycle regulation and oncogenic signaling in MTC.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...